Tonix Pharmaceuticals Holding Corp. sell dimontalban
Start price
02.06.22
/
50%
€18.14
Target price
02.06.23
€0.000
Performance (%)
-36.84%
End price
12.06.22
€11.46
Summary
This prediction ended on 12.06.22 with a price of €11.46. The SELL prediction by dimontalban for Tonix Pharmaceuticals Holding Corp. performed very well with a performance of -36.84%. dimontalban has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - |
| iShares Core DAX® | 1.080% | -2.933% | 12.885% |
| iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% |
| iShares Nikkei 225® | -1.155% | -1.155% | 5.073% |
| iShares S&P 500 | 0.806% | 4.388% | 30.269% |
According to dimontalban what are the pros and cons of Tonix Pharmaceuticals Holding Corp. for the foreseeable future?
Pros
positive Cash Flow expected
Capable Management
Very good company culture
Innovative
Some uniques
Sustainability is very important
Stable Large shareholder and/or long term investor
Cons
Risky balance sheet
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Low dividend yield expected
Bad rating
Very little Investments for future growth
High challenges to pay loans and raise capital
Dependend from some customers or products
Growths slower than the competition
High risks for its business
Very high cyclical dependencies
Below average Marketposition
Unknown brand
Outdated or very high risk business model
Comments by dimontalban for this prediction
In the thread Tonix Pharmaceuticals Holding diskutieren
Sell mit Kursziel 0,0